Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-211-0 | CAS number: 117-81-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Remarks:
- Type of genotoxicity: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study well documented, meets accepted scientific standard, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Lack of genotoxic activity of di(2-ethylhexyl) phthalate (DEHP) in rat and human hepatocytes.
- Author:
- Butterworth BE, Bermudez E, Smith-Oliver T, Earle L
- Year:
- 1 984
- Bibliographic source:
- Carcinogenesis 5, 1329-1335
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 486 (Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Type of assay:
- unscheduled DNA synthesis
Test material
- Reference substance name:
- Bis(2-ethylhexyl) phthalate
- EC Number:
- 204-211-0
- EC Name:
- Bis(2-ethylhexyl) phthalate
- Cas Number:
- 117-81-7
- Molecular formula:
- C24H38O4
- IUPAC Name:
- 1,2-bis(2-ethylhexyl) benzene-1,2-dicarboxylate
- Details on test material:
- - Purity>99.5%
- Source: Dr John R. Hodgson, Tenneco Chemicals, Saddle Brook, NJ or Eastman Chemical Products, Kingsport, TN
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: harles River Breeding Laboratories (Kingston, NY)
- Age at study initiation: no data
- Weight at study initiation: no data
- Assigned to test groups randomly: yes
- Fasting period before study:
- Housing: in hanging stainless steel mesh cages (Hazleton Systems Inc., Vienna, VA) in a mass air displacement room (Bioclean, Hazleton Systems Inc., Vienna, VA)
- Diet (e.g. ad libitum): ad libitum (NIH-07 open formula pelleted chow, Ziegler Bros., Gardner, PA
- Water (e.g. ad libitum): ad libitum tap water
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 70+/-2°F (20-22°C)
- Humidity (%): 50+/-5
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Duration of treatment / exposure:
- 14 days (gavage) or 30 days (in diet)
- Frequency of treatment:
- daily (gavage) or ad libitum (diet)
- Post exposure period:
- 2, 12, 24, 48 hours
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
150, 500 mg/kg
Basis:
nominal conc.
by gavage
- Remarks:
- Doses / Concentrations:
12000 ppm
Basis:
nominal in diet
- No. of animals per sex per dose:
- at least 3 animals per group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- DMN was given by gavage as a freshly prepared water solution.
2-AAF was given by gavage as a suspension in corn oil.
Examinations
- Tissues and cell types examined:
- Hepatocytes
- Details of tissue and slide preparation:
- Hepatocyte cultures were prepared at the times indicated after treatment.
After an attachment period of 1.5 h cultures were incubated with 10 µCi/ml [3H]thymidine (Amersham, Arlington Heights, IL) for 4 h followed by 14-16 h in medium containing no radioactivity.
Autoradiography was performed with a 14 day exposure period. - Evaluation criteria:
- Silver grains over the nucleus minus the grains over an equal sized area in the cytoplasm was defined as net grains per nucleus (NG) and was quantitated with an automatic grain counter.
A negative number indicates there were more grains per unit area in the cytoplasm than in the nucleus. A cell with greater than 5 NG was considered in repair for both rat and human cells. One hundred and fifty cells were counted per data point for the in vitro rat studies and Cases 2 and 3 of the human study. Two hundred cells were counted per data point for Case 1 of the human study. Fifty cells were counted per slide, for three slides, for three animals (450 cells) for each data point for the in vivo experiments.
Cells in S-phase are easily recognized by the very dense labelling of silver grains over the nuclei. The percentage of tells in S-phase was determined for 1000 tells per slide for three slides, for three animals (9000 cells) per data point.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- at 1000 mg/kg the hepatocytes exhibited altered morphology and were badly clumped togethe
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- No DNA repair was observed in male rat hepatocytes treated with 500 mg/kg DEHP at 2, 12, 24 or 48 h before sacrifice.
There was also no response with 1000 mg/kg at 12 h but the cells exhibited altered morphology and were badly clumped together; therefore, the 500 mg/kg dose was chosen for the remainder of the study.
There was also no response in male rats treated with 150 mg/kg/day DEHP for 14 consecutive days. No DNA damage as measured by strand breakage was seen in these animals. Hepatic peroxisomal proliferation was evident by electron microscopy and increased levels of hepatic palmitoyl CoA oxidase and carnitine acetyltransferase. There was also an increase in the liver to body weight ratio.
No induction of DNA repair or increased alkaline elution of DNA was seen in hepatocytes from female rats treated with 12 000 ppm DEHP in the diet for 30 days, 500 mg/kg DEHP at 2 h before sacrifice, or the combination of the two treatments.
Female rats treated with DEHP in the diet still produced a positive DNA repair response with 2-AAF. The alkaline elution response with the positive control 2-AAF was minimal and not nearly as great as that produced with DMN.
Hepatic peroxisomal proliferation had taken place in these animals as evidenced by electron microscopy and a large increase in palmitoyl CoA oxidase and carnitine acetyltransferase.
Although autoradiography did not demonstrate any DEHP induced DNA repair, DEHP did cause a 10-fold increase in the percentage of cells in S-phase in the male animals at the 24 h time point and in the animals given DEHP by gavage for 2 weeks. The percentage of hepatocytes in S-phase in the control female rats was higher than that seen in the male rats (Table IV). The female rats given DEHP in the diet showed only a doubling of the percent of cells in S-phase; however, the final percentage was greater than that observed in the treated males.
Any other information on results incl. tables
Response of DEHP in the in vivo-in vitro male rat hepatocyte DNA repair assay | ||||||||
|
Treatment | Net nuclear grains (NG) ± SE a | Percent of cells with > 5 NG ± SE b | Percent of cells in S-phase ± SD e | ||||
DEHP d | 500 mg/kg, 2 h e | -5.3 | ± 0.2 | 1 | ± 0.3 | 0.01 | ± 0.02 | |
DEHP | 500 mg/kg, 12 h | -1.7 | ± 0.5 | 8 | ± 3 | 0.03 | ± 0.0 | |
DEHP | 500 mg/kg, 24 h | -5.4 | ± 0.3 | 1 t 1 | 0.55 | ± 0.29 | ||
DEHP | 500 mg/kg, 48 h | -3.1 | ± 0.2 | 4 | ± 2 | 0.01 | ± 0.02 | |
DEHP | 150 mg/kg/day for 14 days f | -5.6 | ± 0.6 | 1 | ± 0.4 | 0.50 | ± 0.17 | |
DEHP/DMN | 150 mg/kg/DEHP for 14 days | 18.1 | ± 4.4 | 79 | ± 9 | |||
10 mg/kg DMN at 2 h | ||||||||
DMN | 10 mg/kg, 2 h | 59.2 | ± 17.2 | 96 | ± 2 | |||
DMN | 10 mg/kg, 12 h | 38.9 | ± 13.1 | 89 | ± 5 | |||
Corn oil | 2 ml/kg, 2 h | - 3.3 | ± 0.9 | 5 | ± 4 | 0.03 | ± 0.06 | |
Corn oil | 2 ml/kg, 12 h | -6.0 | ± 0.5 | 1 | ± 0.4 | 0.03 | ± 0.03 | |
Corn oil | 2 ml/kg, 24 h | -4.7 | ± 0.2 | 0.3 | ± 0.3 | 0.07 | ± 0.09 | |
a Standard errors shown represent animal to animal variation for at least three animais, three slides per animal, 50 cells per slide. The values for the 24 h corn oil and 12 h DMN are from two animais. The values for the 2 h corn oil are from one animal, SE is slide to slide variation. Results are consistent with historical positive and negative controls. | ||||||||
b Cells with ? 5 NG are considered in repair. | ||||||||
c Standard deviation shown is animal to animal variation for at least three animais, three slides per animal, 1000 cells per slide. | ||||||||
d DEHP was administered in corn oil by gavage at 1 ml/kg body weight. DMN was administered by gavage in water at 1 m1/kg body weight. | ||||||||
e Time shown is the interval between dosing the animal and perfusing the liver. | ||||||||
f Last dose was given 2 h before liver perfusion. |
Response of DEHP in the in vivo-in vitro female rat hepatocyte DNA repair assay | ||||||
Compound | Treatment | Net nuclear grains (NG) f SE a | Percent of cells with 5 NG ± Seb | Percent of cells in S-phase± SD c | ||
Control | Control diet for 30 days | -3.8 | ± 0.6 | 3 ± 2 | 0.41 | ± 0.20 |
DEHP | 12 000 ppm DEHP diet for 30 days | -3.0 | ± 0.9 | 3 ± 2 | 0.90 | ± 0.36 |
Control/DEHP | Control diet for 50 days 500 mg/kg DEHP at 2 h d | - 5.0 | ± 1.2 | 3 ± 1 | 0.63 | ± 0.67 |
DEHP/DEHP | 12 000 p.p.m. DEHP diet for 30 days 500 mg/kg DEHP at 2 h | -2.8 | ± 0.6 | 3 ± 2 | 0.66 | ± 0.39 |
Control/2-AAF | Control diet for 30 days 50 mg/kg 2-AAF at 15 h | 10.6 | ± 2.2 | 73 ± 17 | ||
DEHP/2-AAF | 12 000 p.p.m. DEHP diet for 30 days 50 mg/kg 2-AAF at 15 h | 6.2 | ± 0.3 | 56 ± 5 | ||
Control/2-AAF | Cells from control animals in culture 20 h with 0.01 mM 2-AAF | 43.5 | ± 0.6 | 97 ± 1 | ||
a Standard errors shown represent animal variation for three animais, three slides per animal, 50 cells per slide. Values for the in vivo 2-AAF are from one animal each and standard errors represent slide to slide variation. The in vitro 2-AAF is animal to animal variation from two animais. | ||||||
bCells with >5 NG are considered in repair. | ||||||
c Standard deviation shown is animal to animal variation for three animais, three slides per animal, 1000 cells per slide. | ||||||
d DEHP and 2-AAF were administered in corn oil by gavage at 2 ml/kg body weight. Time given is the interval between dosing the animal and perfusing the liver. |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
- Executive summary:
The ability of DEHP to induce DNA damage or repair was examined in rat hepatocytes in vivo. Unscheduled DNA synthesis was measured by incorporation of [3H]thymidine into primary hepatocyte cultures immediately isolated from treated animals. DNA damage was measured by alkaline elution of cellular DNA from the same cultures.
In vivo-in vitro treatment regimens were: (i) female rats, 12 000 p.p.m. DEHP in the diet for 30 days; (ii) female rats, 12 000 p.p.m. in the diet for 30 days, followed by 500 mg/kg DEHP by gavage 2 h before sacrifice; (iii) male rats, 500 mg/kg DEHP by gavage 2, 12, 24, or 48 h before sacrifice; and (iv) male rats, 150 mg/kg/day by gavage for 14 days.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.